Strict rules 'stifling' kratom industry, claims ministry
INSUBCONTINENT EXCLUSIVE:
The Justice Ministry is urging the Food and Drug Administration (FDA) to review its regulations on the level of mitragynine allowed in
kratom products after potential investors complained the rule is stifling interest.
